StockData
NervGen Pharma Corp. logo

NervGen Pharma Corp. (NGEN) stock

NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.96+0.14 (+7.69%)

Close on Nov 17, 2026Market cap $156.11MP/E –Yield –

NervGen Pharma EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for NervGen Pharma

NervGen Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More NervGen Pharma figures

See a number that looks wrong?